Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Kinast

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Virulence|November 8, 2018
Human monocyte-derived macrophages inhibit HCMV spread independent of classical antiviral cytokinesJennifer Becker, Volker Kinast, Marius Döring, et al.
Emerging Microbes & Infections|June 27, 2025
Interferon-induced immune signatures are associated with suppression of HEV infection in porcine cell culture modelsSarah Schlienkamp, Olinda Pinto Veiga, André Gömer, et al.
Antiviral Research|June 21, 2022
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replicationDimas F Praditya, Mara Klöhn, Yannick Brüggemann, et al.
Antiviral Research|July 24, 2018
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivoDaniel Todt, Nora Moeller, Dimas Praditya, et al.
Hepatology Communications|November 19, 2024
The tyrosine kinase Yes1 is a druggable host factor of HEVJil Alexandra Haase, Abarna Baheerathan, Xin Zhang, et al.
Cells|June 21, 2019
Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human LiverVolker Kinast, Stefan L Leber, Richard J P Brown, et al.
Viruses|August 28, 2021
Clinical Course of Infection and Cross-Species Detection of Equine Parvovirus-HepatitisBirthe Reinecke, Mara Klöhn, Yannick Brüggemann, et al.
Hepatology (Baltimore, Md.)|May 10, 2024
Targeting cellular cathepsins inhibits hepatitis E virus entryMara Klöhn, Thomas Burkard, Juliana Janzen, et al.
Iscience|August 2, 2021
A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotesDaniel Todt, Toni Luise Meister, Barbora Tamele, et al.
Hepatology (Baltimore, Md.)|February 6, 2023
EGF receptor modulates HEV entry in human hepatocytesJil A Schrader, Thomas L Burkard, Yannick Brüggemann, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Virulence|November 8, 2018
Human monocyte-derived macrophages inhibit HCMV spread independent of classical antiviral cytokinesJennifer Becker, Volker Kinast, Marius Döring, et al.
Emerging Microbes & Infections|June 27, 2025
Interferon-induced immune signatures are associated with suppression of HEV infection in porcine cell culture modelsSarah Schlienkamp, Olinda Pinto Veiga, André Gömer, et al.
Antiviral Research|June 21, 2022
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replicationDimas F Praditya, Mara Klöhn, Yannick Brüggemann, et al.
Antiviral Research|July 24, 2018
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivoDaniel Todt, Nora Moeller, Dimas Praditya, et al.
Hepatology Communications|November 19, 2024
The tyrosine kinase Yes1 is a druggable host factor of HEVJil Alexandra Haase, Abarna Baheerathan, Xin Zhang, et al.
Cells|June 21, 2019
Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human LiverVolker Kinast, Stefan L Leber, Richard J P Brown, et al.
Viruses|August 28, 2021
Clinical Course of Infection and Cross-Species Detection of Equine Parvovirus-HepatitisBirthe Reinecke, Mara Klöhn, Yannick Brüggemann, et al.
Hepatology (Baltimore, Md.)|May 10, 2024
Targeting cellular cathepsins inhibits hepatitis E virus entryMara Klöhn, Thomas Burkard, Juliana Janzen, et al.
Iscience|August 2, 2021
A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotesDaniel Todt, Toni Luise Meister, Barbora Tamele, et al.
Hepatology (Baltimore, Md.)|February 6, 2023
EGF receptor modulates HEV entry in human hepatocytesJil A Schrader, Thomas L Burkard, Yannick Brüggemann, et al.
Pageof 3